- Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26–e51. doi:10.1164/rccm.202002-0251ST.
- Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018–1032. doi:10.1056/NEJMra2101555.
- Bergner R, Löffler C. Renal sarcoidosis: approach to diagnosis and management. Curr Opin Pulm Med. 2018;24(5):513–520. doi:10.1097/MCP.0000000000000504.
- Correia F, Marchini GS, Torricelli FC, et al. Renal manifestations of sarcoidosis: from accurate diagnosis to specific treatment. Int Braz J Urol. 2020;46(1):15–25. doi:10.1590/S1677-5538.IBJU.2019.0042.
- Komatsuda A, Wakui H, Ohtani H, et al. Amyloid A-type renal amyloidosis in a patient with sarcoidosis: report of a case and review of the literature. Clin Nephrol. 2003;60(4):284–288. doi:10.5414/cnp60284.
- Maroz N, Field H. Necrotizing crescentic glomerulonephritis related to sarcoidosis: a case report. J Med Case Rep. 2015;9:282.
- Stehlé T, Joly D, Vanhille P, et al. Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study. Orphanet J Rare Dis. 2013;8:65. doi:10.1186/1750-1172-8-65.
- Giraudo C, Nannini N, Balestro E, et al. Necrotizing sarcoid granulomatosis with an uncommon manifestation: clinicopathological features and review of literature. Respir Care. 2014;59(9):e132–e136. doi:10.4187/respcare.02842.
- Parejo-Morón AI, Tornero-Divieso ML, Férnandez-Díaz MR, Muñoz-Medina L, Preda O, Ortego-Centeno N. Necrotizing sarcoid granulomatosis: a disease not to be forgotten. Case Rep Med. 2020;2020:5730704. doi:10.1155/2020/5730704.
- Huggins JT, Doelken P, Sahn SA, King L, Judson MA. Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest. 2006;129(6):1599–1604. doi:10.1378/chest.129.6.1599.
- Rivera E, Gesthalter Y, Vardelaan P, Chee A, Majid A. Sarcoidosis with pleural effusion as the presenting symptom. J Bronchology Interv Pulmonol. 2018;25(2):148–151. doi:10.1097/LBR.0000000000000453.
- Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1443. doi:10.3389/fimmu.2020.01443.
- Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6:369–377. doi:10.2147/CLEP.S39981.
- Dasari S, Theis JD, Vrana JA, et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 2020;95(9):1852–1864. doi:10.1016/j.mayocp.2020.06.029.
- Nagata M, Shimokama T, Harada A, Koyama A, Watanabe T. Glomerular crescents in renal amyloidosis: an epiphenomenon or distinct pathology? Pathol Int. 2001;51(3):179–186. doi:10.1046/j.1440-1827.2001.01188.x.
- Zuckerman JE, Peng F, Karl BE, Schulze CE, Sisk A. Cancer-associated AA amyloidosis presenting as crescentic glomerulonephritis. Kidney Int Rep. 2019;4(6):882–887. doi:10.1016/j.ekir.2019.02.017.
- Schafernak KT, Chugh SS, Kanwar YS. Co-existent crescentic glomerulonephritis and renal amyloidosis: a case report and literature review. J Nephrol. 2005;18(5):616–622.
- Neild GH, Ribitsch W, Tsybrovskyy O, et al. AA-amyloidosis in a kidney biopsy on top of pauci-immune crescentic glomerulonephritis. Clin Kidney J. 2012;5(1):73–74. doi:10.1093/ndtplus/sfr136.
- Verine J, Mourad N, Desseaux K, et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol. 2007;38(12):1798–1809. doi:10.1016/j.humpath.2007.04.013.
- Masutani K, Nagata M, Ikeda H, et al. Glomerular crescent formation in renal amyloidosis. A clinicopathological study and demonstration of upregulated cell-mediated immunity. Clin Nephrol. 2008;70(12):464–474. doi:10.5414/CNP70464.
- Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17(5):1253–1263. doi:10.1681/ASN.2005091013.
- Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29(155):190146. doi:10.1183/16000617.0146-2019.
- Brunger AF, Nienhuis HLA, Bijzet J, Hazenberg BPC. Causes of AA amyloidosis: a systematic review. Amyloid. 2020;27(1):1–12. doi:10.1080/13506129.2019.1693359.
- Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458–3471. doi:10.1681/ASN.2006050460.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 5
Case Studies
Sarcoidosis-associated renal AA amyloidosis and crescentic necrotizing glomerulonephritis
Albert Buia Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida
https://orcid.org/0000-0002-2927-7885
, DO, PharmDhttps://orcid.org/0000-0002-2927-7885, Cherise Corteseb Department of Pathology, Mayo Clinic, Jacksonville, Floridahttps://orcid.org/0000-0001-7307-6565
, MDhttps://orcid.org/0000-0001-7307-6565 & Nabeel Aslamc Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, FloridaCorrespondenceaslam.nabeel.mayo.edu
https://orcid.org/0000-0003-2735-0951
, MDhttps://orcid.org/0000-0003-2735-0951